ZHEJIANG KANGLE PHARMACEUTICAL CO.,LTD.

W1A12
China Mainland
Company Profile
  • Year Established: 1945
  • Total Assets(USD): 6,000,000 to 6,999,999
  • Total Number of Staff: more than 500
  • Main Competitive Advantages:
  • Business Type: Manufacturer,Other,Trading Company
  • Annual Turnover(USD) : Choose not to disclose
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

As one of the largest API manufactuer in China with advanced GMP facilities,we offer high-qualified Paracetamol,Paracetamol DC, Paracetamol tablet and Paracetamol Microcaps with US FDA, EU GMP and COS approval. We are reputed for excellent quality and first-class service. We have established business relation with many multi-national pharmaceutical companies. Erdosteine API is also our strong product with GMP certification and KFDA approval. Besides this, we produce various kinds of finished dosages. .

Year Established: 1945

Total Assets(USD): 6,000,000 to 6,999,999

Total Number of Staff: more than 500

Main Competitive Advantages:

Business Type: Manufacturer,Other,Trading Company

Annual Turnover(USD) : Choose not to disclose

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Top Products
Certificates/Standards
Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by